BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 17289129)

  • 21. The vascular endothelial growth factor (VEGF) +405G>C 5'-untranslated region polymorphism and increased risk of endometriosis in South Indian women: a case control study.
    Bhanoori M; Arvind Babu K; Pavankumar Reddy NG; Lakshmi Rao K; Zondervan K; Deenadayal M; Kennedy S; Shivaji S
    Hum Reprod; 2005 Jul; 20(7):1844-9. PubMed ID: 15746194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular endothelial growth factor (VEGF) gene (VEGFA) polymorphism can predict the prognosis in acute myeloid leukaemia patients.
    Kim DH; Lee NY; Lee MH; Sohn SK; Do YR; Park JY
    Br J Haematol; 2008 Jan; 140(1):71-9. PubMed ID: 17983459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascular endothelial growth factor gene polymorphisms are associated with the risk of developing adenomyosis.
    Kang S; Zhao J; Liu Q; Zhou R; Wang N; Li Y
    Environ Mol Mutagen; 2009 Jun; 50(5):361-6. PubMed ID: 19197986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. VEGF-A and i-NOS expression are prognostic factors in serous epithelial ovarian carcinomas after complete surgical resection.
    Engels K; du Bois A; Harter P; Fisseler-Eckhoff A; Kommoss F; Stauber R; Kaufmann M; Nekljudova V; Loibl S
    J Clin Pathol; 2009 May; 62(5):448-54. PubMed ID: 19126566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of polymorphisms -1154G/A and -2578C/A in the vascular endothelial growth factor gene with decreased risk of endometriosis in Chinese women.
    Liu Q; Li Y; Zhao J; Sun DL; Duan YN; Wang N; Zhou RM; Kang S
    Hum Reprod; 2009 Oct; 24(10):2660-6. PubMed ID: 19531502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A polymorphism in the matrix metalloproteinase-1 gene promoter is associated with the prognosis of patients with ovarian cancer.
    Six L; Grimm C; Leodolter S; Tempfer C; Zeillinger R; Sliutz G; Speiser P; Reinthaller A; Hefler LA
    Gynecol Oncol; 2006 Mar; 100(3):506-10. PubMed ID: 16214204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular endothelial growth factor expression in ovarian cancer: a model for targeted use of novel therapies?
    Duncan TJ; Al-Attar A; Rolland P; Scott IV; Deen S; Liu DT; Spendlove I; Durrant LG
    Clin Cancer Res; 2008 May; 14(10):3030-5. PubMed ID: 18483368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single nucleotide polymorphisms and haplotypes in the gene for vascular endothelial growth factor and risk of prostate cancer.
    Langsenlehner T; Langsenlehner U; Renner W; Krippl P; Mayer R; Wascher TC; Kapp KS
    Eur J Cancer; 2008 Jul; 44(11):1572-6. PubMed ID: 18514506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular endothelial growth factor and its soluble receptor in benign and malignant ovarian tumors.
    Artini PG; Ruggiero M; Monteleone P; Carpi A; Cristello F; Cela V; Genazzani AR
    Biomed Pharmacother; 2008; 62(6):373-7. PubMed ID: 18037256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of -634G/C and 936C/T polymorphisms of the vascular endothelial growth factor with spontaneous preterm delivery.
    Papazoglou D; Galazios G; Koukourakis MI; Kontomanolis EN; Maltezos E
    Acta Obstet Gynecol Scand; 2004 May; 83(5):461-5. PubMed ID: 15059159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potentially functional polymorphisms of the vascular endothelial growth factor gene and risk of gastric cancer.
    Ke Q; Liang J; Wang LN; Hu ZB; Jin GF; Zhou Y; Wang JM; Tan YF; Hua ZL; Xu YC; Shen J; Shen HB
    Mol Carcinog; 2008 Aug; 47(8):647-51. PubMed ID: 18383582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Maspin overexpression correlates with increased expression of vascular endothelial growth factors A, C, and D in human ovarian carcinoma.
    Bolat F; Gumurdulu D; Erkanli S; Kayaselcuk F; Zeren H; Ali Vardar M; Kuscu E
    Pathol Res Pract; 2008; 204(6):379-87. PubMed ID: 18343598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional polymorphisms in the vascular endothelial growth factor gene are associated with development of end-stage renal disease in males.
    Doi K; Noiri E; Nakao A; Fujita T; Kobayashi S; Tokunaga K
    J Am Soc Nephrol; 2006 Mar; 17(3):823-30. PubMed ID: 16421229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gender-specific association between polymorphism of vascular endothelial growth factor (VEGF 936 C>T) gene and colon cancer in Korea.
    Bae SJ; Kim JW; Kang H; Hwang SG; Oh D; Kim NK
    Anticancer Res; 2008; 28(2B):1271-6. PubMed ID: 18505065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of polymorphisms in vascular endothelial growth factor gene with the age of onset of amyotrophic lateral sclerosis.
    Chen D; Shen L; Wang L; Lu A; Zhang H; Zhang X; Zhang Y; Shui W; Li L; Fan D; Zhang J
    Amyotroph Lateral Scler; 2007 Jun; 8(3):144-9. PubMed ID: 17538775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Co-expression of angiogenic markers and associations with prognosis in advanced epithelial ovarian cancer: a Gynecologic Oncology Group study.
    Secord AA; Darcy KM; Hutson A; Lee PS; Havrilesky LJ; Grace LA; Berchuck A;
    Gynecol Oncol; 2007 Jul; 106(1):221-32. PubMed ID: 17481705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic importance of vascular endothelial growth factor-A expression and vascular endothelial growth factor polymorphisms in epithelial ovarian cancer.
    Smerdel MP; Waldstrøm M; Brandslund I; Steffensen KD; Andersen RF; Jakobsen A
    Int J Gynecol Cancer; 2009 May; 19(4):578-84. PubMed ID: 19509553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular endothelial growth factor gene 460 polymorphism is associated with pterygium formation in female patients.
    Tsai YY; Chiang CC; Bau DT; Cheng YW; Lee H; Tseng SH; Tsai FJ
    Cornea; 2008 May; 27(4):476-9. PubMed ID: 18434853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vascular endothelial growth factor gene polymorphisms in thyroid cancer.
    Hsiao PJ; Lu MY; Chiang FY; Shin SJ; Tai YD; Juo SH
    J Endocrinol; 2007 Nov; 195(2):265-70. PubMed ID: 17951537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The reduction in pigment epithelium-derived factor is a sign of malignancy in ovarian cancer expressing low-level of vascular endothelial growth factor.
    Tsuchiya T; Nakahama K; Asakawa Y; Maemura T; Tanaka M; Takeda S; Morita M; Morita I
    Gynecol Endocrinol; 2009 Feb; 25(2):104-9. PubMed ID: 19253105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.